Review Article
Development of Viral Vectors for Gene Therapy for Chronic Pain
Table 1
Analgesic effect of HSV vectors encoding therapeutic genes in pain treatment.
| Pain models | Gene product | Inoculation | References |
| Acute pain | Preproenkephalin | To the skin of dorsal hindpaw | Wilson et al. [16] | Inflammatory pain | Preproenkephalin A | Infected on scarified hind footpads | Braz et al. [17] | Neuropathic pain | Proenkephalin A | Unilateral peripheral inoculation | Meunier et al. [21] | Cutaneous hyperalgesia | Preproenkephalin | Subcutaneous inoculation | Yeomans et al. [9] | Bladder hyperactivity and pain | Preproenkephalin | Injected into the bladder wall | Yokoyama et al. [20] | Inflammatory pain | Endomorphin-2 | Subcutaneous inoculation | Hao et al. [18] | Neuropathic pain | Endomorphin-2 | Subcutaneous inoculation | Wolfe et al. [19] | Neuropathic pain | IL-4 | Subcutaneous inoculation | Hao et al. [23] | Neuropathic pain | sTNFRs | Subcutaneous inoculation | Peng et al. [24] | Neuropathic pain | GAD67 | Subcutaneous inoculation | Hao et al. [25] | Neuropathic pain | GAD67 | Subcutaneous inoculation | Liu et al. [26] | Inflammatory pain | Nav1.7 antisense | Subcutaneous inoculation | Yeomans et al. [27] | Cancer pain | Proenkephalin | Subcutaneous inoculation | Goss et al. [14] |
|
|